Parada B, Figueiredo A, Nunes P, Bastos C, Macário F, Roseiro A, Dias V, Rolo F, Mota A
Department of Urology and Renal Transplantation, University Hospital of Coimbra, Coimbra, Portugal.
Transplant Proc. 2005 Jul-Aug;37(6):2771-4. doi: 10.1016/j.transproceed.2005.05.046.
To retrospectively review our experience with pediatric renal transplantation and to compare the results with the adult population.
Between January 1981 and August 2003, 74 renal transplants were performed in patients < or =18 years at the time of the transplant--the pediatric group versus 1153 patients in the adult group. We analyzed various risk factors for actuarial kidney graft and patient survivals using the Kaplan-Meier method.
Median ages were 13.8 +/- 3.5 and 42.6 +/- 2.4 years, respectively. There was no statistically significant difference in the human leukocyte antigen matching or immunosuppression. There was, however, a younger donor age and shorter ischemia time in the pediatric group. Overall, kidney transplant survival rates for patients < or =18 years at 1, 2, 5, and 10 years were 94.4%, 91.3%, 70.6%, and 58.2%, respectively, with no significant difference for patients older than 18 (91.2%, 89.3%, 78.8%, 60.5%, P = .4325). There was a significantly decreased graft survival in the adult group at 10 years when the donor age was over 60 years and when the ischemia time was > or =20 hours. The incidence of delayed graft function and the creatinine levels of functioning grafts did not differ between the two groups. During the follow-up, acute rejections were more frequent in the younger group. Patient survival in the pediatric group at 1, 2, 5, and 10 years was 98.6%, 98.8%, 98.6%, and 90.3%, respectively, significantly lower in the adult group (95.3%, 94.0%, 87.9%, 76.8%, P < .02).
Renal transplantation may be successfully performed in the pediatric patients with end-stage renal disease. Overall graft survival at 10 years did not differ significantly between the two groups. There is a higher incidence of acute rejections but longer patient survival in the pediatric population.
回顾性分析我们在小儿肾移植方面的经验,并与成人肾移植结果进行比较。
1981年1月至2003年8月期间,共对74例移植时年龄小于或等于18岁的患者进行了肾移植——即小儿组,成人组有1153例患者。我们采用Kaplan-Meier方法分析了影响肾移植存活和患者生存的各种危险因素。
小儿组和成人组的中位年龄分别为13.8±3.5岁和42.6±2.4岁。在人类白细胞抗原配型或免疫抑制方面,两组间无统计学显著差异。然而,小儿组的供体年龄更小,缺血时间更短。总体而言,移植时年龄小于或等于18岁患者的肾移植1年、2年、5年和10年存活率分别为94.4%、91.3%、70.6%和58.2%,18岁以上患者的存活率与之无显著差异(分别为91.2%、89.3%、78.8%、60.5%,P = 0.4325)。当供体年龄超过60岁且缺血时间大于或等于20小时时,成人组10年时的移植肾存活率显著降低。两组间移植肾功能延迟恢复的发生率及功能良好移植肾的肌酐水平无差异。随访期间,小儿组急性排斥反应更为频繁。小儿组患者1年、2年、5年和10年的生存率分别为98.6%、98.8%、98.6%和90.3%,成人组显著更低(分别为95.3%、94.0%、87.9%、76.8%,P < 0.02)。
终末期肾病小儿患者可成功进行肾移植。两组间10年总体移植肾存活率无显著差异。小儿人群急性排斥反应发生率更高,但患者生存时间更长。